Farmasi

Peneliti dari Australia melaporkan hasil positif dari uji klinis Fase II obat berbasis karbohidrat baru untuk mengobati sepsis. Uji coba yang melibatkan 180 pasien di China menunjukkan kemampuan obat tersebut mengurangi keparahan kondisi tersebut. Perkembangan ini menawarkan harapan untuk terapi target pertama terhadap penyebab utama kematian global.

Sabtu, 17 Januari 2026 Dilaporkan oleh AI

A Delhi High Court verdict on January 12 has allowed Indian pharma company Zydus Lifesciences to manufacture and sell a biosimilar version of Bristol Myers-Squibb's cancer drug Nivolumab. This ruling could pave the way for more affordable immunotherapy treatments for cancer patients in India. Nivolumab is effective against various cancers, with its patent set to expire in May 2026.

Egypt's Minister of Health and Population, Khaled Abdel Ghaffar, held an expanded meeting on Monday with representatives of relevant state bodies to discuss ways to support pharmaceutical manufacturers and draft a comprehensive policy framework for boosting local production and localizing biopharmaceutical and biological products.

Jumat, 19 Desember 2025 Dilaporkan oleh AI

Daiichi Sankyo announced it will begin over-the-counter sales of the emergency contraceptive Norlevo on February 2, marking the first time such a pill is available without a prescription in Japan. The pill must be taken in the presence of a trained pharmacist for safety reasons.

Chile's Public Health Institute warned of two new risks linked to leuprorelina-containing drugs, used for advanced prostate cancer treatment. These include liver issues like fatty liver and severe skin reactions that can be fatal. The review drew from international evidence, with no local cases reported in the past 12 years.

Selasa, 02 Desember 2025 Dilaporkan oleh AI

The RD Saúde group, owner of the Raia and Drogasil chains, obtained a license to produce and sell over 20 molecules of over-the-counter medicines starting in 2026. The initiative was announced during the RD Day in São Paulo. The products will be launched under the Bwell brand.